Stockreport

Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting

Ocuphire Pharma, Inc.  (OCUP) 
PDF FARMINGTON HILLS, Mich., May 06, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on deve [Read more]